PACB — Pacific Biosciences of California Share News
0.000.00%
Last trade - 00:00- $609.23m
- $1.02bn
- $160.01m
Nasdaq biotech index hits over 2-1/2 yr high
Pacific Biosciences of California Inc reports results for the quarter ended in March - Earnings Summary
Brief: Pacific Biosciences of California Q1 Adjusted Net Income USD -71.4 Million Vs. IBES Estimate USD -76.2 Million
Pacific Biosciences of California Inc expected to post a loss of 28 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-American Express, Philip Morris, Royal Gold
Brief: Estonia National Biobank Selects PacBio To Sequence 10,000 Whole Genomes
Brief: Pacific Biosciences Of California Announces Puretarget Repeat Expansion Panel, Expanding Its Portfolio Of End-To-End Clinical Research Solutions
U.S. RESEARCH ROUNDUP-Home Depot, Palo Alto Networks, Wendys
Pacific Biosciences of California Inc reports results for the quarter ended in December - Earnings Summary
Brief: Pacific Biosciences of California Q4 Adjusted EPS USD -0.27 Vs. IBES Estimate USD -0.29
Pacific Biosciences of California Inc expected to post a loss of 29 cents a share - Earnings Preview
Brief: PacBio Reports Record Prelim Q4 and Full Year Revenue
Brief: PacBio Announces The Retirement Of David Botstein, From Its Board Of Directors
Pacific Biosciences of California Inc reports results for the quarter ended in September - Earnings Summary
Brief: Pacific Biosciences of California Q3 Adjusted EPS USD -0.27 Vs. IBES Estimate USD -0.33
Pacific Biosciences of California Inc expected to post a loss of 33 cents a share - Earnings Preview
Brief: Pacific Biosciences of California Increases Size Of Board To Ten Directors - SEC Filing
Brief: Pacific Biosciences Of California Appoints David Meline To Board
Brief: Pacific Biosciences Of California Files For Shelf Of Up To 8.99 Mln Shares By Stockholders - SEC Filing